Ropeginterferon ALFA-2B

Intervention1 paper1 finding

Outcomes

1

Neutrophil-to-lymphocyte ratio

downin humans1

1 study

Ropeginterferon ALFA-2B decreases neutrophil-to-lymphocyte ratio in humans.
Reviewduring treatment with ropeginterferon alfa-2b
Neutrophil-to-lymphocyte ratio as a gene-specific biomarker of JAK2-driven inflammation across CHIP and myeloproliferative neoplasms · Frontiers in oncology · 11 Aug 2026

Neutrophil-to-lymphocyte ratio →

Latest

1

Frontiers in OncologyReview26 Aug

Neutrophil-to-lymphocyte ratio as a gene-specific biomarker of JAK2-driven inflammation across CHIP and myeloproliferative neoplasms

Neutrophil-to-lymphocyte ratio